antiretrovirals (Synthelabo)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug Nameantiretrovirals (Synthelabo)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHerpes SimplexHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi-Synthelabo

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi-Synthelabo

Active IndicationsN/A

Inactive IndicationsHerpes SimplexHIV Infections

ATC CodeN/A